Access cutting-edge hsct treatment through this phase 1/2 clinical trial at a research site in Cincinnati. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Cincinnati location
Preparing your pre-screening questions…
Access hsct specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hsct treatment provided free
Check if you qualify for this hsct clinical trial in Cincinnati, OH
No-Cost Study Care
Local to Cincinnati
Convenient for OH residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This will be an un-blinded, open-label study of children and adults, including those who are being evaluated for or who have undergone HSCT, those with existing respiratory conditions and/or diagnosed gas-exchange impairment, and healthy control volunteers. The participants will be male or female between 3-17 years old (children) and adults age 18 and older. The study objective is to: * To optimize the acquisition of images reflecting the "dissolved-phase" Xe distribution in the pulmonary tissues and blood (Xe gas-exchange MRI). * To develop and test Xe MRI acquisition strategies that separately image alveolar airspace distribution (ventilation), as well as Xe dissolved in pulmonary tissues versus red blood cells (RBCs). * To acquire images of Xe ventilation and dissolved-phase Xe regional distribution in the enrolled participants. * To understand the same-day variability of Xe MRI techniques. * To determine the relationship between Xe MRI and clinical measures such as pulmonary-function-test (PFT) parameters or other biological biomarkers. * To develop and optimize strategies for Xe MRI in young children including those who are unable to follow the inhalation and breath-hold instructions typical of the Xe MRI procedure.
Sponsor: Children's Hospital Medical Center, Cincinnati
Yes, this clinical trial (NCT07823036) has an active research site in Cincinnati, OH that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for hsct treatment options in Cincinnati, OH, this clinical trial (NCT07823036) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Cincinnati research site is actively enrolling participants for this phase 1/2 clinical trial. You'll receive care from experienced hsct specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all hsct clinical trials near you to find additional studies recruiting in your area.
See all hidradenitis suppurativa clinical trials recruiting in Cincinnati — not just this study.
Browse Hidradenitis Suppurativa Trials in Cincinnati →